SP has followed pretty much every other H2 stock.
I think he’s been working hard to differentiate Hazer from a whole bunch of electrolysis hype. And to set us up for the next 10 years.
I want to see if those HZROs are in the money by Feb.
And by how much?
Commercial readiness by end of year and beginning of engineering revenues should provide that impetus….
- Forums
- ASX - By Stock
- Venn Brown Rpt 12-08-24
SP has followed pretty much every other H2 stock.I think he’s...
Featured News
Add HZR (ASX) to my watchlist
|
|||||
Last
33.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $77.08M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 21337 | 33.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
33.0¢ | 17 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 21337 | 0.330 |
3 | 28365 | 0.325 |
4 | 12770 | 0.320 |
1 | 16643 | 0.315 |
8 | 56071 | 0.310 |
Price($) | Vol. | No. |
---|---|---|
0.340 | 35000 | 2 |
0.345 | 2977 | 1 |
0.350 | 59473 | 2 |
0.355 | 16939 | 2 |
0.360 | 18563 | 3 |
Last trade - 09.59am 13/08/2024 (20 minute delay) ? |
Featured News
HZR (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online